BAP1 Antikörper (AA 191-326)
Kurzübersicht für BAP1 Antikörper (AA 191-326) (ABIN6654721)
Target
Alle BAP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 191-326
-
Verwendungszweck
- BAP1 Antibody / BRCA1-Associated Protein 1
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 191-326 from the human protein was used as the immunogen for the BAP1 antibody.
-
Isotyp
- IgG2c, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the BAP1 antibody to be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the BAP1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- BAP1 (BRCA1 Associated Protein-1 (Ubiquitin Carboxy-terminal Hydrolase) (BAP1))
-
Andere Bezeichnung
- BAP1
-
Hintergrund
- The BAP1 gene belongs to the ubiquitin C-terminal hydrolase subfamily of de-ubiquitination enzymes that are involved in the removal of ubiquitin from proteins. The encoded enzyme binds to the breast cancer type 1 susceptibility protein (BRCA1) via the RING finger domain of the latter and acts as a tumor suppressor. In addition, the enzyme may be involved in regulation of transcription, regulation of cell cycle and growth, response to DNA damage and chromatin dynamics. Germ line mutations in this gene may be associated with tumor predisposition syndrome (TPDS), which involves increased risk of cancers including malignant mesothelioma, Uveal melanoma and cutaneous melanoma.
-
UniProt
- Q92560
Target
-